申请人:Schering Corporation
公开号:US04497814A1
公开(公告)日:1985-02-05
Disclosed are 2-(pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidines and derivatives which are effective in increasing cardiac contractility. These compounds are useful in the treatment of congestive heart failure preferably by oral or parenteral administration.
本发明揭示了2-(吡啶基)-1,2,4-三唑并[1,5-a]嘧啶及其衍生物,可有效提高心脏收缩力。这些化合物可通过口服或注射途径用于治疗充血性心力衰竭。